<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20181206041868N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-03-27</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Mindfulness and Acceptance and Cognitive Behavioral Group Therapy on adult stuttering</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of Mindfulness and Acceptance Group Therapy in comparison with Cognitive Behavioral Group Therapy on severity of social anxiety, quality of life, and verbal fluency in adults with stuttering</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-04-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>54</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/36149</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization will be done using blocked randomization with fixed block sizes. The size of the blocks will be 6 and randomization will be performed using www.sealedenvelope.com. We will have 9 blocks which every one of them has 6 members (n=54) and the members will be replaced by random sequences created by the website. In each block, two participants will be randomly assigned to group A (Mindfulness and Acceptance Group Therapy), two participants to group B (Cognitive Behavioral Group Therapy), and two participants to group C (Control Group).</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: adult stuttering. Condition 2: social phobia.</hc_freetext>
      <i_freetext>Intervention 1: First Intervention group: Mindfulness and Acceptance Group Therapy plus speech therapy (Smooth Speech); This group, in psychotherapy stage, will be under 10 consecutive weekly 2 hrs sessions group therapy which will have two parts; In first 5 sessions, participants will practice Mindful exercises in addition to learning therapy concepts and in second 5 sessions, Vital Actions. After post test evaluation, participants will be under 4 weekly 4 hrs Smooth Speech Therapy which include teaching principal techniques of the therapy and using these techniques gradually from low to high speed until they can use these techniques in reading and daily speech with normal speed range. Intervention 2: Second Intervention group: Cognitive Behavioral Group Therapy plus speech therapy (Smooth Speech); This group, in psychotherapy stage, will be under 10 consecutive weekly 2 hrs session group therapy which will have two parts. In first 5 sessions, participants will learn cognitive restructuring and in second 5 sessions practice Behavioral experiments and exposures. After post test evaluation, participants will be under 4 weekly 4 hrs Smooth Speech Therapy which include teaching principal techniques of the therapy and using these techniques gradually from low to high speed until participants can use them in reading and daily speech with normal speed range. Intervention 3: Control group: Speech Therapy (Smooth Speech); After being in waiting list and post test evaluation, participants will be under 4 weekly 4 hrs Smooth Speech Therapy which include teaching principal techniques of the therapy and using these techniques gradually from low to high speed until participants can use them in reading and daily speech with normal speed range.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Soroush Khoshnam</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Behavioral Sciences and Mental Health., No. 1., Mansoori Alley ., Niyaeesh Ave ,. Sattarkhan St,. Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۴۵۶۱۳۱۱۱</zip>
        <telephone>+98 21 6655 1655</telephone>
        <email>soroushkhoshnam@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Banafshe Gharraee</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Behavioral Sciences and Mental Health., No. 1., Mansoori Alley ., Niyaeesh Ave ,. Sattarkhan St,. Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۴۵۶۱۳۱۱۱</zip>
        <telephone>+98 21 6655 1655</telephone>
        <email>gharraee.b@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosis: developmental stuttering
language: Persian
Age: more than 20 years
Education: more than 8 classes
Social phobia: moderate and severe</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Psychotic disorders
Drug dependency disorders
Any other primary psychiatric disorders which be so severe that the participant could not tolerate group therapies</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F98.5</hc_code>
      <hc_code>F40.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Stuttering [stammering: ]Speech that is characterized by frequent repetition or prolongation of sounds or syllables or words, or by frequent hesitations or pauses that disrupt the rhythmic flow of speech. It should be classified as a disorder only if its </hc_keyword>
      <hc_keyword>Social phobias: Fear of scrutiny by other people leading to avoidance of social situations. More pervasive social phobias are usually associated with low self-esteem and fear of criticism. They may present as a complaint of blushing, hand tremor, nausea, </hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First Intervention group: Mindfulness and Acceptance Group Therapy plus speech therapy (Smooth Speech); This group, in psychotherapy stage, will be under 10 consecutive weekly 2 hrs sessions group therapy which will have two parts; In first 5 sessions, participants will practice Mindful exercises in addition to learning therapy concepts and in second 5 sessions, Vital Actions. After post test evaluation, participants will be under 4 weekly 4 hrs Smooth Speech Therapy which include teaching principal techniques of the therapy and using these techniques gradually from low to high speed until they can use these techniques in reading and daily speech with normal speed range.</i_keyword>
      <i_keyword>Second Intervention group: Cognitive Behavioral Group Therapy plus speech therapy (Smooth Speech); This group, in psychotherapy stage, will be under 10 consecutive weekly 2 hrs session group therapy which will have two parts. In first 5 sessions, participants will learn cognitive restructuring and in second 5 sessions practice Behavioral experiments and exposures. After post test evaluation, participants will be under 4 weekly 4 hrs Smooth Speech Therapy which include teaching principal techniques of the therapy and using these techniques gradually from low to high speed until participants can use them in reading and daily speech with normal speed range.</i_keyword>
      <i_keyword>Control group: Speech Therapy (Smooth Speech); After being in waiting list and post test evaluation, participants will be under 4 weekly 4 hrs Smooth Speech Therapy which include teaching principal techniques of the therapy and using these techniques gradually from low to high speed until participants can use them in reading and daily speech with normal speed range.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Severity of social anxiety. Timepoint: The evaluation of severity of social anxiety before the start of psychotherapy, after the termination of psychotherapy, after speech therapy, and after 3 month follow up. Method of measurement: Social Phobia and Anxiety Inventory.</prim_outcome>
      <prim_outcome>Quality of life. Timepoint: The evaluation of quality of life before the start of psychotherapy, after the termination of psychotherapy, after speech therapy, and after 3 month follow up. Method of measurement: Overall Assessment of the Speaker's Experience of Stuttering-Adults.</prim_outcome>
      <prim_outcome>Severity of Stuttering. Timepoint: The evaluation of severity of stuttering before the start of psychotherapy, after the termination of psychotherapy, after speech therapy, and after 3 month follow up. Method of measurement: Stuttering Severity Instrument-3.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-03-17</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Iran University of Medical Sciences, Shahid Hemmat Highway, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
